Hydroxy/Hydroperoxy/Epoxy/Oxo Eicosanoids
Products Related to Hydroxy/Hydroperoxy/Epoxy/Oxo Eicosanoids(138)
- GC41652(±)14(15)-EpEDECAS: 351533-80-7Purity: >98.00%
8,11,14-Eicosatrienoic acid, also known as dihomo-γ-linolenic acid, is a polyunsaturated fatty acid (PUFA) produced from γ-linolenic acid by the action of fatty acid elongases.
- GC41662(±)5(6)-EET EthanolamidePurity: >95.00%
Arachidonyl ethanolamide is an endogenous lipid neurotransmitter with cannabinergic activity, binding to both the central cannabinoid (CB1) and peripheral cannabinoid (CB2) receptors.
- GC41665(±)8(9)-EET EthanolamidePurity: >98.00%
Arachidonoyl ethanolamide (AEA; anandamide) is an endogenous lipid neurotransmitter with cannabinergic activity, binding to both the central cannabinoid (CB1) and peripheral cannabinoid (CB2) receptors.
- GC4188212(S)-HETrECAS: 72710-10-2Purity: >98.00%
12(S)-HETrE is produced by 12-lipoxygenase oxidation of dihomo-γ-linolenic acid (DGLA).
- GC4208320-HETE EthanolamideCAS: 942069-11-6Purity: >98.00%
Arachidonoyl ethanolamide (AEA) is an endogenous lipid neurotransmitter with cannabinergic activity, binding both the central cannabinoid (CB1) and peripheral cannabinoid (CB2) receptors.
- GC4208420-hydroxy Arachidic Acid methyl esterCAS: 37477-29-5Purity: >98.00%
20-hydroxy Arachidic acid methyl ester is a hydroxylated fatty acid methyl ester that has been found in P.
- GC4208520-hydroxy N-Arachidonoyl TaurinePurity: >95.00%
Arachidonic acid is metabolized by cytochrome P450 (CYP450) 4A ω-hydroxylase to 20-HETE, which acts as a vasoconstrictor in the kidney and brain.
- GC421622-hydroxy Arachidic Acid methyl esterCAS: 16742-49-7Purity: >98.00%
2-hydroxy Arachidic acid methyl ester is a hydroxylated fatty acid methyl ester that has been found in sediment samples from the Harney River and in petroleum ether extracts of I.
- GC424795(S)-HETrECAS: 195061-94-0Purity: >98.00%
5(S)-HETrE is produced by the action of 5-LO when mead acid is the substrate.
- GC426198(S)-HETrECAS: 889573-69-7Purity: >98.00%
8(S)-HETrE is a monohydroxy polyunsaturated fatty acid produced by rabbit neutrophil lipoxygenase when dihomo-γ-linolenic acid is used as a substrate.
- GC45023tetranor-12(R)-HETECAS: 135271-51-1Purity: >98.00%
Metabolism of 12(R)-HETE in corneal tissue produces predominantly the compound resulting from the loss of four carbon atoms through β-oxidation from C-1.
- GC45024tetranor-12(S)-HETECAS: 121842-79-3Purity: >98%
12(S)-HETE is a product of arachidonic acid metabolism through the 12-lipoxygenase pathway.
- GC45271(±)11(12)-EET EthanolamidePurity: >98.00%
Arachidonoyl ethanolamide (AEA; anandamide) is an endogenous lipid neurotransmitter with cannibingeric activity, binding to both the central cannabinoid (CB1) and peripheral cannabinoid (CB2) receptors.
- GC45920(±)14(15)-EET-d11 methyl esterPurity: >99.00%
A neuropeptide with diverse biological activities
- GC45922(±)11(12)-EET-d11 methyl esterPurity: >99.00%
A neuropeptide with diverse biological activities
| Catalog No. | Product Name | CAS No. | Purity | Structure |
|---|---|---|---|---|
| GC41652 | (±)14(15)-EpEDE | 351533-80-7 | >98.00% | |
8,11,14-Eicosatrienoic acid, also known as dihomo-γ-linolenic acid, is a polyunsaturated fatty acid (PUFA) produced from γ-linolenic acid by the action of fatty acid elongases. | ||||
| GC41662 | (±)5(6)-EET Ethanolamide | - | >95.00% | |
Arachidonyl ethanolamide is an endogenous lipid neurotransmitter with cannabinergic activity, binding to both the central cannabinoid (CB1) and peripheral cannabinoid (CB2) receptors. | ||||
| GC41665 | (±)8(9)-EET Ethanolamide | - | >98.00% | |
Arachidonoyl ethanolamide (AEA; anandamide) is an endogenous lipid neurotransmitter with cannabinergic activity, binding to both the central cannabinoid (CB1) and peripheral cannabinoid (CB2) receptors. | ||||
| GC41882 | 12(S)-HETrE | 72710-10-2 | >98.00% | |
12(S)-HETrE is produced by 12-lipoxygenase oxidation of dihomo-γ-linolenic acid (DGLA). | ||||
| GC41940 | 15-OxoEDE | 105835-44-7 | >95.00% | |
15-OxoEDE is produced by the oxidation of 15-HEDE. | ||||
| GC42083 | 20-HETE Ethanolamide | 942069-11-6 | >98.00% | |
Arachidonoyl ethanolamide (AEA) is an endogenous lipid neurotransmitter with cannabinergic activity, binding both the central cannabinoid (CB1) and peripheral cannabinoid (CB2) receptors. | ||||
| GC42084 | 20-hydroxy Arachidic Acid methyl ester | 37477-29-5 | >98.00% | |
20-hydroxy Arachidic acid methyl ester is a hydroxylated fatty acid methyl ester that has been found in P. | ||||
| GC42085 | 20-hydroxy N-Arachidonoyl Taurine | - | >95.00% | |
Arachidonic acid is metabolized by cytochrome P450 (CYP450) 4A ω-hydroxylase to 20-HETE, which acts as a vasoconstrictor in the kidney and brain. | ||||
| GC42162 | 2-hydroxy Arachidic Acid methyl ester | 16742-49-7 | >98.00% | |
2-hydroxy Arachidic acid methyl ester is a hydroxylated fatty acid methyl ester that has been found in sediment samples from the Harney River and in petroleum ether extracts of I. | ||||
| GC42479 | 5(S)-HETrE | 195061-94-0 | >98.00% | |
5(S)-HETrE is produced by the action of 5-LO when mead acid is the substrate. | ||||
| GC42619 | 8(S)-HETrE | 889573-69-7 | >98.00% | |
8(S)-HETrE is a monohydroxy polyunsaturated fatty acid produced by rabbit neutrophil lipoxygenase when dihomo-γ-linolenic acid is used as a substrate. | ||||
| GC45023 | tetranor-12(R)-HETE | 135271-51-1 | >98.00% | |
Metabolism of 12(R)-HETE in corneal tissue produces predominantly the compound resulting from the loss of four carbon atoms through β-oxidation from C-1. | ||||
| GC45024 | tetranor-12(S)-HETE | 121842-79-3 | >98% | |
12(S)-HETE is a product of arachidonic acid metabolism through the 12-lipoxygenase pathway. | ||||
| GC45271 | (±)11(12)-EET Ethanolamide | - | >98.00% | |
Arachidonoyl ethanolamide (AEA; anandamide) is an endogenous lipid neurotransmitter with cannibingeric activity, binding to both the central cannabinoid (CB1) and peripheral cannabinoid (CB2) receptors. | ||||
| GC45919 | (±)5(6)-EET-d11 methyl ester | - | >99.00% | |
A neuropeptide with diverse biological activities | ||||
| GC45920 | (±)14(15)-EET-d11 methyl ester | - | >99.00% | |
A neuropeptide with diverse biological activities | ||||
| GC45921 | (±)8(9)-EET-d11 methyl ester | - | >99.00% | |
A neuropeptide with diverse biological activities | ||||
| GC45922 | (±)11(12)-EET-d11 methyl ester | - | >99.00% | |
A neuropeptide with diverse biological activities | ||||
| GC46252 | (±)11(12)-DiHET-d11 | - | >99.00% | |
A neuropeptide with diverse biological activities | ||||
| GC46258 | (±)14(15)-DiHET-d11 | - | >99.00% | |
A neuropeptide with diverse biological activities | ||||
| GC46260 | (±)17(18)-EpETE | - | >90.00% | |
A neuropeptide with diverse biological activities | ||||
| GC46262 | (±)5(6)-EET-d11 | - | >99.00% | |
A neuropeptide with diverse biological activities | ||||
| GC46264 | (±)8(9)-EET-d11 | - | >99.00% | |
A neuropeptide with diverse biological activities | ||||
| GC46265 | (±)8,9-DiHET-d11 | - | >99.00% | |
A neuropeptide with diverse biological activities | ||||